Researchers at NREL found that UV exposure can cause significant, partly non-recoverable degradation in TOPCon solar cells, with strong cell-to-cell and intra-cell variability linked to passivation ...
ImmunityBio commands a premium valuation on the promise of Anktiva, a chemo-free immunotherapy platform showing early efficacy and manageable safety. Learn more about IBRX stock here.
Live Science on MSN
Diagnostic dilemma: 83-year-old man's unusual form of syphilis had an 'uncertain' source
A man went to the emergency room after being in and out of hospitals for a month, and doctors found a surprising explanation ...
Citi's 2026 Virtual Oncology Leadership Summit February 18, 2026 10:45 AM ESTCompany ParticipantsSamarth Kulkarni - CEO ...
Global South World on MSN
Kenya becomes first East African country to receive lenacapavir, long-acting HIV prevention drug
The first batch arrived on Tuesday, February 17, marking a new phase in HIV prevention efforts in the country, where 1.4 million people are living with HIV. Lenacapavir is administered as an injection ...
Kenya has received 21,000 starter doses for an initial roll-out across 15 priority counties selected based on their HIV ...
South Africa will launch Lenacapavir, a six-month HIV prevention injection, in six provinces, targeting all HIV-negative ...
Cryptopolitan on MSN
Federal Reserve to inject $16 billion in liquidity into U.S. markets this week
The Federal Reserve will inject $16,021,000,000 into the U.S. financial system this week through scheduled bill purchases, ...
Taseko Mines Limited (TSX: TKO; NYSE American: TGB; LSE: TKO) ("Taseko" or the "Company") reports full year 2025 Adjusted ...
New designation is based on data showing rapid and durable responses in a heavily pretreated patient population and expands the promise of RYBREVANT ...
Final Milestone in Strategic Transformation Positions Company to Accelerate IM8 Global Expansion with Zero Debt ...
New designation is based on data showing rapid and durable responses in a heavily pretreated patient population and expands the promise of RYBREVANT FASPRO beyond lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results